As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping the future of aging research.
AI is Compressing Decades of Longevity Research into Weeks
Metatrend #4: Longevity, Medicine & Biotechnology
What it is
AI is accelerating longevity research *millions-fold*.
On my recent Moonshots podcast with David Sinclair, PhD, he explained how his Harvard lab is now completing experiments in one month that would have previously taken "hundreds of thousands of years to accomplish" using tradi…
Healthcare today is reactive, retrospective, bureaucratic and expensive. It's sick care, not healthcare.
But that is radically changing at an exponential rate.
Last year alone, we saw nearly $800 million invested in longevity startups — over double the approximate $400 million invested in 2017.
Through this multi-part blog series on Longevity, I’ll take a deep dive into aging, longevity technolog…
Peter and Dan discuss takeaways fromAbundance 360, Peter’s executive summit where four rockstar longevity CEOs summarized new capabilities in the healthcare industry. These cutting-edge companies, whose early experiments have produced amazing results, will have therapies and drugs on the market in the next one to five years.
In this episode:
Peter mentions Mark Allen, the CEO of Elevian, on the “…
